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Is it Chikungunya or Dengue?
Chikungunya and dengue are viruses most commonly transmitted by Aedes aegypti and Aedes albopictus mosquitoes. 
Anyone who lives in or has traveled to an area where chikungunya or dengue viruses are found is at risk for infection.
Chikungunya virus Dengue virus
• Approximately 3 in 4 people infected 
will develop disease.
• Incubation: 3–7 days (range: 2–12 days)
• Acute symptoms typically resolve within 7-10 days.
• Persons at risk for severe disease include neonates 
exposed intrapartum, older adults, and persons with 
underlying medical conditions.
• Infection is thought to confer lifetime immunity.
• Risk areas: http://www.cdc.gov/chikungunya/geo/index.html
• Approximately 1 in 4 people infected will develop disease.
• Incubation: 4–7 days (range: 3–14 days)
• Some patients may develop life threatening consequences and 
require hospitalization. 
• Since there are 4 distinct dengue viruses, a person can be 
infected up to 4 times. Infection with each dengue virus type 
confers lifetime immunity for that specific virus type.  
• Risk areas: http://www.cdc.gov/dengue/
 
Signs and Symptoms Signs and Symptoms
• Chikungunya begins as an acute febrile illness.
• Disease causes polyarthralgia; pain can be severe. Other 
common symptoms include headache, muscle pain, joint 
swelling, and rash.
• Some patients have persistence or relapse of rheumatologic 
symptoms in the months following acute illness. 
• Mortality is rare and occurs mostly in older adults.
Dengue is an acute febrile illness that can vary in severity over a 5–7 day 
period.  Recognizing warning signs for severe dengue and providing 
appropriate medical management can prevent morbidity and death. 
Febrile Phase: Lasts 2–7 days after being bitten; can be biphasic.
• Fever with 2 or more of the following: Headache, retro-orbital pain, 
joint pain, muscle and/or bone pain, rash, mild bleeding (nose or 
gums, easy bruising), neutropenia
Critical Phase: Begins at defervescence, lasts 24–48 hours. Most patients 
improve but severe disease requiring hospitalization can occur. 
• Warning signs: Evidence of plasma leakage–abdominal 
pain, persistent vomiting (at least 3 episodes/24 hours), 
clinical fluid accumulation, liver enlargement >2 cm, 
mucosal bleeding, lethargy or restlessness, 
hemoconcentration (hHCT with rapid thrombocytopenia)
Recovery Phase (patient improvement):
• Gradual reabsorption of extravasated fluid from plasma leakage over 
48–72 hours; diuresis; hemodynamic status stabilizes; patient can 
temporarily become bradycardic (but hemodynamically stable)
www.cdc.gov/chikungunya 
www.cdc.gov/dengue
Treatment for Chikungunya and Dengue
Treat symptoms: Assess hydration and hemodynamic status and provide 
supportive care as needed.  If adequate, instruct the patient to rest and 
drink fluids.
Treat or manage other conditions:  Evaluate for other serious conditions 
(e.g., malaria and bacterial infections).
Relieve fever and pain: Recommend acetaminophen or paracetamol until 
dengue is ruled out. Aspirin and NSAIDs (like ibuprofen) can increase risk of 
bleeding in patients with dengue. NSAIDs, corticosteroids, or physiotherapy 
may help treat persistent joint pain.
Reduce risk of further transmission:  Patients should protect themselves 
from further mosquito bites during the first week of illness to reduce the 
risk of local transmission. Vaccines are not available.
 
Diagnostic Testing: Test for both Chikungunya and Dengue 
•  Collect serum samples and order tests for both diseases. 
•  Contact your state health department for more information and to facilitate testing. 
•  For information on submitting diagnostic specimens for testing, including PRNT, 
to CDC: http://www.cdc.gov/ncezid/dvbd/specimensub/arboviral-shipping.html
Report Cases of Chikungunya and Dengue
• Both infections and diseases are nationally notifiable conditions. 
•  Contact state or local health department to report suspected and confirmed cases. 
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Report positive test results to state or local health department
Test for CHIKV antibody using
Anti-CHIKV IgM ELISA or IFA
CHIKUNGUNYA (CHIKV) VIRUS  



















Test for DENV antibody using
Anti-DENV IgM ELISA 
DENGUE VIRUSES (DENV 1, 2, 3, AND 4)  
Test for DENV viral RNA using RT-PCR
and Anti-DENV antibody using IgM ELISA
Dengue = one or both tests positive









4 Report positive test results to state or local health department
• Cross-reaction with IgM antibodies against related flaviviruses (e.g., dengue, St. Louis encephalitis, West Nile, 
and Zika viruses) is common in areas where there is co-circulation of viruses.
•  Plaque-reduction neutralization testing (PRNT) can be performed to measure virus-specific neutralizing 
antibodies and discriminate between cross-reacting antibodies in primary flavivirus infections.
Report Cases of Chikungunya and Dengue
• Both chikungunya and dengue virus diseases are nationally notifiable conditions. 
•  Contact state or local health department to report suspected and confirmed cases. 
Diagnostic Testing: Test for both Chikungunya and Dengue
•  Collect serum samples and order tests for both diseases. 
•  Contact your state health department for more information and to facilitate testing. 
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